









Markets
/
Stocks
/
nasdaq-evmn
/

Evommune Inc

EVMN

19.060USD

-0.520-2.66%

Close 01/27, 16:00（ET）Quotes delayed by 15 min

573.28MMarket Cap

LossP/E TTM



Evommune Inc

19.060

-0.520-2.66%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of Evommune Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

Total equity

Cash, cash equivalents and short-term investments

--86.80M

- Cash and cash equivalents

--61.84M

-Short-term investments

--24.96M

Prepaid expenses

--8.10M

Total current assets

--94.89M

Non-current assets

Net Fixed Assets

--1.05M

Other non-current assets

--269.00K

Total non-current assets

--1.31M

Total assets

--96.21M

Liabilities

Current liabilities

-Other payables

--38.00K

Accrued expenses

--5.92M

Short-term debt and lease liabilities

--394.00K

-Short-term debt

--0.00

-Short-term lease liabilities

--394.00K

Deferred liabilities

--0.00

Other current liabilities

--38.00K

Total current liabilities

--10.09M

Non-current liabilities

Long-term debt and lease liabilities

--0.00

Other non-current liabilities

---1.00K

Total non-current liabilities

--346.00K

Total liabilities

--10.44M

Shareholders' equity

Common equity

--9.11M

Preferred equity

--257.00M

Retained earnings

---180.34M

Capital reserves

--9.11M

Total equity

--85.77M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

